Antidepressant Discontinuation Symptoms: What They Are and What to Do

What is antidepressant discontinuation syndrome?

Discontinuation syndrome is not the same as addiction or withdrawal in the substance-dependence sense 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse. Antidepressants do not cause cravings or compulsive drug-seeking — you are not dependent on them the way someone might be on opioids or alcohol. What happens is that your brain's neurochemistry adapts to the presence of the medication over time, and when it is suddenly removed, it takes time to readjust.

Discontinuation syndrome is recognized in the clinical literature as a distinct and predictable phenomenon. The discomfort is real, but it is also manageable and time-limited when handled correctly 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse2Ref 2Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018).Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.Systematic review documenting discontinuation symptoms across SNRI medications including venlafaxine; confirms short half-life as the key risk driver.

What are the symptoms of antidepressant discontinuation?

Symptoms typically appear within one to four days of stopping (or missing doses of) an antidepressant and usually resolve within one to two weeks — though the timeline varies by medication and individual 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse. The most commonly recognized symptoms form a cluster described by the acronym FINISH 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse:

• Flu-like symptoms: fatigue, muscle aches, sweating, chills, nausea
• Insomnia: difficulty sleeping, vivid or disturbing dreams
• Nausea: often prominent, sometimes with vomiting or diarrhea
• Imbalance: dizziness, lightheadedness, coordination difficulties
• Sensory disturbances: including the well-known "brain zaps" — brief electrical or shock-like sensations in the head or body
• Hyperarousal or anxiety: increased anxiety, irritability, restlessness

Brain zaps deserve special mention because they are particularly distinctive and alarming if you do not know what they are. They are brief, electrical-sensation jolts — some people describe them as a flash, a whoosh, or a tingling zap. They are not dangerous but are often the most unsettling part of discontinuation 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse.

Which antidepressants are more likely to cause discontinuation symptoms?

The risk is closely tied to a medication's half-life — how long it takes to clear from your body 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse2Ref 2Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018).Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.Systematic review documenting discontinuation symptoms across SNRI medications including venlafaxine; confirms short half-life as the key risk driver.

Higher risk (shorter half-lives): paroxetine, venlafaxine, duloxetine, and desvenlafaxine are among the most commonly associated with significant discontinuation symptoms.

Lower risk (longer half-lives): fluoxetine (Prozac) is the most notable example — its very long half-life means it effectively tapers itself, and discontinuation symptoms are uncommon with it.

SNRIs such as venlafaxine can produce particularly pronounced symptoms even with brief missed doses, given their short half-life 2Ref 2Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018).Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.Systematic review documenting discontinuation symptoms across SNRI medications including venlafaxine; confirms short half-life as the key risk driver. Individual responses vary considerably; your prescribing clinician can give you a more personalized picture.

How do you stop an antidepressant safely?

The recommended approach is a gradual taper — slowly reducing your dose over weeks to months under clinician guidance 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse3Ref 3National Institute of Mental Health (2023).Depression.NIMH guidance that antidepressants should not be stopped abruptly; recommended treatment duration after symptom remission; importance of clinician-guided tapering to reduce relapse risk. The appropriate pace depends on how long you have been on the medication, which medication it is, and how you respond. Some people do well with a relatively quick taper; others, particularly those who have been on a medication for a long time or at a high dose, benefit from a much slower reduction.

Clinical guidelines consistently advise against abrupt discontinuation of antidepressants 3Ref 3National Institute of Mental Health (2023).Depression.NIMH guidance that antidepressants should not be stopped abruptly; recommended treatment duration after symptom remission; importance of clinician-guided tapering to reduce relapse risk. If you stopped abruptly and are now experiencing symptoms, contact your prescribing clinician. Restarting the medication at your previous dose typically brings rapid relief of discontinuation symptoms, after which a structured taper can be planned.

Do not attempt to manage severe or prolonged symptoms on your own without clinician input.

How do you tell discontinuation apart from relapse?

This distinction matters, because stopping an antidepressant too soon (before completing the full recommended course) increases the risk of relapse into depression or anxiety 3Ref 3National Institute of Mental Health (2023).Depression.NIMH guidance that antidepressants should not be stopped abruptly; recommended treatment duration after symptom remission; importance of clinician-guided tapering to reduce relapse risk. In general:

• Discontinuation symptoms tend to be primarily physical (brain zaps, dizziness, flu-like feelings), appear within days of stopping, and improve quickly if the medication is restarted
• Relapse tends to be more emotional (persistent low mood, loss of interest, return of worry), develops more gradually over weeks, and does not typically include brain zaps or dizziness 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Clinical description of antidepressant discontinuation syndrome including the FINISH mnemonic, half-life and risk stratification by medication, timeframe for symptom onset and resolution, and guidance on distinguishing discontinuation from relapse

The two can overlap, and clinician involvement is important for distinguishing them. Do not wait to seek assessment if you are uncertain — the stakes of misidentifying a relapse are significant 3Ref 3National Institute of Mental Health (2023).Depression.NIMH guidance that antidepressants should not be stopped abruptly; recommended treatment duration after symptom remission; importance of clinician-guided tapering to reduce relapse risk.